Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02130986 · ClinicalTrials.gov registry record · NA
Procalcitonin Antibiotic Consensus Trial (ProACT)
A NA study of Lower Respiratory Tract Infection (LRTI), sponsored by University of Pittsburgh.
- Completed
- Registry status
- NA
- Development phase
- 1,664
- Enrollment target
- 13
- Study locations
NCT02130986 is a NA study of Lower Respiratory Tract Infection (LRTI) that has completed, run by University of Pittsburgh. The registered enrollment target is 1,664 participants. The trial reports 13 study locations across 10 states.
The verdict
NCT02130986, a NA study of Lower Respiratory Tract Infection (LRTI), has completed, sponsored by University of Pittsburgh.
- COMPLETED
- Registry status
- NA
- Development phase
- 1,664 participants
- Enrollment target
- 13
- Study locations
Study Summary
The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency Department (ED) patients with Lower Respiratory Tract Infection (LRTI).
Conditions Studied
Interventions
- OTHER Procalcitonin level
- OTHER Results of procalcitonin (PCT) level to treating clinician
- OTHER Provide procalcitonin guideline to treating clinician
- OTHER Telephone Visit
Study Locations (13)
Massachusetts
- Massachusetts General Hospital - Boston
- Brigham and Women's Hospital - Boston
- Beth Israel Deaconess Medical Center - Boston
Pennsylvania
- Penn State Hershey College of Medicine; Milton S. Hershey Medical Center - Hershey
- University of Pittsburgh Medical Center - Pittsburgh
Alabama
- University of Alabama at Birmingham - Birmingham
Arizona
- Maricopa Medical Center - Phoenix
California
- University of California at Irvine Medical Center - Orange
Connecticut
- Norwalk Hospital - Norwalk
Maryland
- University of Maryland/Baltimore - Baltimore
Michigan
- Wayne State University/Detroit Receiving Hospital - Detroit
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,664 participants |
| Start Date | 2014-11-03 |
| Est. Completion | 2017-07-21 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02130986
The ClinicalTrials.gov registry entry for NCT02130986 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 1,664 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Pittsburgh, which has 1,238 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Lower Respiratory Tract Infection (LRTI) appearing as the primary indexed condition, and to 4 interventions - of which Procalcitonin level is the first listed.
NCT02130986 reports 13 study locations spanning 10 distinct geographic areas - top geographies include Massachusetts, Pennsylvania, Alabama.
Frequently Asked Questions
What is clinical trial NCT02130986 about?
NCT02130986 is a clinical study titled "Procalcitonin Antibiotic Consensus Trial (ProACT)". The ProACT study is a 5 year, multicenter study that will test the effect of implementation of a novel procalcitonin guideline on antibiotic use and adverse outcomes in Emergency Department (ED) patients with Lower Respiratory Tract Infection (LRTI).
What is the current status of trial NCT02130986?
This trial is currently completed. It is a NA study. The enrollment target is 1,664 participants. The study started on 2014-11-03. Estimated completion is 2017-07-21.
What conditions does trial NCT02130986 study?
This clinical trial studies the following conditions: Lower Respiratory Tract Infection (LRTI).
What interventions are being tested in trial NCT02130986?
The interventions under investigation include: Procalcitonin level (OTHER), Results of procalcitonin (PCT) level to treating clinician (OTHER), Provide procalcitonin guideline to treating clinician (OTHER), Telephone Visit (OTHER).
Who is sponsoring clinical trial NCT02130986?
This trial is sponsored by University of Pittsburgh, which has 1,238 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02130986 being conducted?
This trial has 13 study locations across Alabama, Arizona, California, Connecticut, Maryland. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.